Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Stelexis BioSciences, Inc. logo — company profile

Stelexis BioSciences, Inc.

Founded 2017 United States New York, United States 17 employees

General Information

Company Name Stelexis BioSciences, Inc.
Founded Year 2017
Location United States New York, United States +2
Employees 17
Social

Get notified when Stelexis BioSciences, Inc. moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Stelexis BioSciences, Inc.

Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.

No funding data available for Stelexis BioSciences, Inc. yet.

Get notified when Stelexis BioSciences, Inc. raises funding

Stelexis BioSciences, Inc. Alternatives & Competitors

Stelexis BioSciences, Inc. vs
PIC Therapeutics
PIC Therapeutics United States

Modulating Oncogene Translation to Dramatically Improve Cancer Patient Outcomes

Series A
8 employees
Biotechnology, Health Care
Stelexis BioSciences, Inc. vs
SOLID Therapeutics
SOLID Therapeutics Denmark

An early-stage oncology company aiming to treat solid tumors

Unknown
5 employees
Stelexis BioSciences, Inc. vs
ViroCure
ViroCure Korea South

ViroCure is at the forefront of cancer therapeutics research and vaccine development with oncolytic...

Series Unknown
5 employees
Health and Wellness

FAQ About Stelexis BioSciences, Inc.

Stelexis is a Deerfield founded and solely funded New York-based cancer therapeutics company with a mission of transforming cancer therapeutics paradigm and patient care, through the discovery and development of novel drugs.
Stelexis BioSciences, Inc. was founded in 2017.
Stelexis BioSciences, Inc. is headquartered in New York, United States.
Stelexis BioSciences, Inc. has approximately 17 employees.
Top alternatives and competitors to Stelexis BioSciences, Inc. include PIC Therapeutics, SOLID Therapeutics, ViroCure, Halda Therapeutics, Raze Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Stelexis BioSciences, Inc. and PIC Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Stelexis BioSciences, Inc. and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy

Book a demo 30 minutes